文章名稱引用次數(shù)

• Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using US Administrative Claims Data20
• Factors Affecting Health Care Provider Knowledge and Acceptance of Biosimilar Medicines: A Systematic Review16
• Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration16
• Burden of Illness in Type 2 Diabetes Mellitus15
• Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease13
• The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies13
• Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2-Advanced or Metastatic Breast Cancer: A US Payer Perspective12
• Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database11
• Integrating Innovative Telehealth Solutions into an Interprofessional Team-Delivered Chronic Care Management Pilot Program10
• Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life Products10